Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Haleon plc
Front panels for 34 SKUs for Haleon’s Nicorette 2- and 4-mg gum in approved to include a superimposed letter N; labeling approved for seven SKUs for Kenvue’s Zyrtec Allergy 5- and 10-mg tablets to include “new” for six months.
Futura Medical has extended its licensing agreement with Cooper Consumer Health for the rights to market its Eroxon topical, gel-based erectile dysfunction treatment throughout the European Economic Area, United Kingdom and Switzerland until 2029.
The largest shareholder in major Japanese pharma firm Taisho, the founding Uehara family, intends to smooth the way to the restructuring and expansion of the business by acquiring and delisting all of its stock. The nearly $5bn size of the deal would makes it the biggest management buyout in Japanese corporate history.
Larger consumer health firms are “looking to move-the-needle opportunities, which are big brands, big categories, different regions than we compete in as part of their business objective,” says CEO Ron Lombardi as PCH reports revenues down slightly from year-ago period at $286.3m.
- OTC, Consumer
- Other Names / Subsidiaries
- GSK/Pfizer JV
- Hindustan Milkfood Manufacturers Pvt Ltd
- HMM Ltd.
- SmithKline Beecham Brands Ltd.
- SmithKline Beecham Consumer Healthcare Ltd.
- GlaxoSmithKline Consumer Healthcare Limited
- GSK Consumer Healthcare
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.